Search
Friday 2 October 2015
  • :
  • :

Traders Alert: Ship Finance International Limited (NYSE:SFL), Pra Group Inc (NASDAQ:PRAA), Quiksilver, Inc. (NYSE:ZQK), ImmunoGen, Inc. (NASDAQ:IMGN)

On Monday, in the course of current trade, Shares of Ship Finance International Limited (NYSE:SFL), climbed 0.36%, and is now trading at $16.80.

Ship Finance International Limited, declared its preliminary financial results for the quarter ended June 30, 2015.

Highlights

  • Increased second quarter dividend of $0.44 per share
  • Acquisition of eight Capesize dry bulk carriers with long-term charters
  • Acquisition of three 9,300-9,500 TEU container vessels with long-term charters
  • Revised charter terms and 28% ownership in Frontline
  • Notes and warrants in Horizon Lines sold for $72 million
  • Sale of 1995-built Suezmax crude oil tanker

Ship Finance International Limited owns and operates vessels and offshore related assets in Bermuda, Cyprus, Malta, Liberia, Norway, Singapore, the United Kingdom, and the Marshall Islands. It is also involved in the charter, purchase, and sale of assets.

During an Afternoon trade, Shares of Pra Group Inc (NASDAQ:PRAA), climbed 0.07%, and is now trading at $53.39.

PRA Group reported its financial results for the second quarter of 2015.

Second Quarter Highlights

  • Cash collections of $389.6 million, up 22% from the second quarter of 2014.
  • Revenues of $237.2 million, up 20%.
  • Income from operations of $88.9 million, up 23%. The second quarter of 2014 included costs and foreign exchange currency losses associated with the Aktiv Kapital acquisition. Excluding these costs in the second quarter of 2014, income from operations would have increased 16%.
  • Net income of $51.4 million, up 37%. Excluding the costs in the second quarter of 2014 associated with the Aktiv Kapital acquisition, net income would have increased 17%.
  • $1.06 diluted earnings per share, compared with $0.74 in the year-ago quarter, up 43%. Excluding the costs in the second quarter of 2014 associated with the Aktiv Kapital acquisition, diluted earnings per share would have increased 22%.
  • 5% return on average equity, annualized.
  • $208.4 million in investments.

PRA Group, Inc., a financial and business service company, engages in the purchase, collection, and management of portfolios of defaulted consumer receivables in North America and Europe. It is involved in the acquisition, collection, and processing of unpaid and normal-course accounts receivable owed to credit grantors, governments, retailers, and others.

Shares of Quiksilver, Inc. (NYSE:ZQK), during its Monday’s current trading session fell -7.99%, and is now trading at $0.425.

Quiksilver, declared that it plans to issue a press release reporting its fiscal 2015 third quarter financial results after the market closes on Wednesday, September 9, 2015, and will conduct a conference call the same day at 4:30 p.m. Eastern Time to review its results.

Quiksilver, Inc. designs, develops, and distributes branded apparel, footwear, accessories, and related products primarily for men, women, and children. The company provides its products for various activities, including casual and outdoor lifestyle associated with surfing, skateboarding, snowboarding, BMX and motocross, rally car, and other activities.

Finally, ImmunoGen, Inc. (NASDAQ:IMGN), lost -6.23% Monday.

ImmunoGen, declared that investors, journalists and the general public are invited to listen to a live webcast of the Company’s analyst and investor community meeting on September 18, 2015.

The event will focus on ImmunoGen’s strong foundation for growth, including the advancement of its multi-product pipeline, its proprietary technology that is enabling the development of novel anticancer therapies and the Company’s core competencies that position it for success.

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. The company offers Kadcyla, an antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *